I-BOP, the most potent radiolabelled agonist for the TXA2/PGH2 receptor.
Morinelli
T A
TA
Department of Cell and Molecular Pharmacology, Medical University of South Carolina, Charleston 29425.
Mais
D E
DE
Oatis
J E
JE
Mayeux
P R
PR
Okwu
A K
AK
Masuda
A
A
Knapp
D R
DR
Halushka
P V
PV
D001667:Binding, Competitive; D001792:Blood Platelets / Q000378:metabolism*; D001643:Bridged Bicyclo Compounds / Q000378:metabolism* / Q000494:pharmacology; D019086:Bridged Bicyclo Compounds, Heterocyclic; D001952:Bridged-Ring Compounds / Q000378:metabolism*; D005231:Fatty Acids, Unsaturated / Q000378:metabolism* / Q000494:pharmacology; D006801:Humans; D007457:Iodine Radioisotopes; D007700:Kinetics; D015394:Molecular Structure; D009119:Muscle Contraction / Q000187:drug effects; D009131:Muscle, Smooth, Vascular / Q000502:physiology; D010974:Platelet Aggregation / Q000187:drug effects; D011982:Receptors, Prostaglandin / Q000378:metabolism*; D017482:Receptors, Thromboxane; D012501:Saphenous Vein / Q000502:physiology
D001643:Bridged Bicyclo Compounds; D019086:Bridged Bicyclo Compounds, Heterocyclic; D001952:Bridged-Ring Compounds; D005231:Fatty Acids, Unsaturated; D007457:Iodine Radioisotopes; D011982:Receptors, Prostaglandin; D017482:Receptors, Thromboxane; C061750:7-(3-(3-hydroxy-4-(4'-iodophenoxy)-1-butenyl)-7-oxabicyclo(2.2.1)heptan-2-yl)-5-heptenoic acid